Company Filing History:
Years Active: 2007
Title: Michael J Parma: Innovator in Positron Emission Tomography
Introduction
Michael J Parma is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of nuclear medicine, particularly in the area of positron emission tomography (PET). His innovative work has led to the development of a patented technology that enhances the capabilities of medical imaging.
Latest Patents
Michael J Parma holds a patent for "Real-time list mode reconstruction" in positron emission tomography. This technology utilizes a nuclear medicine scanner to detect gamma-ray events resulting from positron annihilation events. Molecules with known behaviors are tagged with radioactive isotopes that decay into gamma-ray pairs, which are detected coincidentally by radiation detectors. A temporal recorder and a subject support monitor indicate the time and position of the subject when the coincident gamma-rays are detected. A storage buffer collects gamma-ray detection times and locations along with support positions. Every 1/100 to 1/10 second, a batch of data collected in the buffer is reconstructed into overlapping portions of an image memory as the support moves continuously through the scanner.
Career Highlights
Michael J Parma is associated with Koninklijke Philips Corporation N.V., where he applies his expertise in medical imaging technologies. His work has been instrumental in advancing the capabilities of PET scanners, making them more efficient and effective for clinical use.
Collaborations
One of his notable collaborators is Gerd Muehllehner, with whom he has worked on various projects related to nuclear medicine and imaging technologies.
Conclusion
Michael J Parma's contributions to the field of positron emission tomography exemplify the impact of innovation in medical imaging. His patented technology continues to enhance the accuracy and efficiency of diagnostic procedures, ultimately benefiting patient care.